JayantKumarMD

Clinical Trials

• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) Start of enrollment: 2009 Apr 01

  Withdrawn

  Phase 3

• Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor Start of enrollment: 2011 Apr 01

  Completed

  Phase 2

• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis Start of enrollment: 2013 Sep 03

  Completed

  Phase 3

• Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa Start of enrollment: 2014 Mar 12

  Completed

  Phase 3

• Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus Start of enrollment: 2014 Jun 01

  Completed

  Phase 2, Phase 3

• Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis Start of enrollment: 2015 Jan 15

  Completed

  Phase 3

• Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy Start of enrollment: 2018 Feb 15

  Completed

  Phase 3

• Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa Start of enrollment: 2019 Jan 31

  Completed

  Phase 2

• Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria Start of enrollment: 2019 Nov 01

  Not yet recruiting

  Phase 4

• Join now to see all